Skip to main content
PeopleBio, Inc. logo

PeopleBio, Inc. — Investor Relations & Filings

Ticker · 304840 ISIN · KR7304840002 KO Manufacturing
Open in API
Filings indexed 250 across all filing types
Latest filing 2020-09-28 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 304840

About PeopleBio, Inc.

http://www.peoplebio.net/en/PEOPLEBIO.p…

PeopleBio, Inc. is a biotechnology company specializing in the development and manufacturing of diagnostic products for protein misfolding diseases. The company's primary focus is on degenerative brain disorders, particularly Alzheimer's disease. It develops blood-based diagnostic kits and immunoassays designed for early detection. By providing tools for early diagnosis, PeopleBio aims to facilitate timely intervention and treatment, thereby improving patient outcomes for these conditions.

Recent filings

Filing Released Lang Actions
[발행조건확정]증권신고서(지분증권)
Share Issue/Capital Change Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Services Commission (금융위원회) in South Korea. It details a correction (정정신고서) to a previous filing regarding the finalization of the public offering price (공모가액 확정) for PeopleBio Co., Ltd. This type of document is a formal regulatory filing related to capital raising and share issuance, which falls under the 'Regulatory Filings' category as it is a specific legal document for securities registration.
2020-09-28 Korean
[기재정정]투자설명서
Capital/Financing Update Classification · 95% confidence The document is a '정정신고서' (Amendment Filing) for an '투자설명서' (Prospectus) regarding a public offering of shares by PeopleBio. It details changes to the offering price (from a range of 25,000-30,000 KRW to a fixed price of 20,000 KRW) and associated financial figures. In the context of financial filings, a prospectus amendment related to capital raising and share issuance is classified under 'Share Issue/Capital Change'.
2020-09-28 Korean
투자설명서
Capital/Financing Update Classification · 95% confidence The document is a 'Securities Registration Statement' (투자설명서) for PeopleBio, detailing the company's intent to list on the KOSDAQ market. It includes sections on offering terms, risk factors (business, financial, and market risks), and valuation methodologies. This is a formal regulatory filing required for an Initial Public Offering (IPO) in South Korea, which falls under the category of Proxy Solicitation & Information Statement (PSI) or general Regulatory Filings (RNS). Given the specific nature of the document as a prospectus for public offering, it is classified as a Proxy Solicitation & Information Statement (PSI) as it serves to inform potential investors and solicit their participation in the offering.
2020-09-22 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '정정신고(보고)' (Correction Report) for a '증권신고서(지분증권)' (Securities Registration Statement for Equity Securities). This is a formal regulatory filing submitted to the Financial Supervisory Service (FSS) in South Korea, detailing amendments to a previously filed registration statement regarding a public offering (IPO) of PeopleBio Co., Ltd. Since it is a formal regulatory amendment document rather than a standalone report or announcement, it falls under the category of Regulatory Filings.
2020-09-11 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a 'Securities Registration Statement' (증권신고서) filed with the Financial Supervisory Service (DART) in South Korea. It details the registration of equity securities for a public offering, including information on the issuer (PeopleBio), offering terms, risk factors, and management confirmation. This is a formal regulatory filing required for companies planning an IPO or capital raise, which falls under the 'Regulatory Filings' category as it is a primary registration document.
2020-09-02 Korean
[기재정정]증권신고서(지분증권)
Capital/Financing Update Classification · 98% confidence The document is a '증권신고서(지분증권) 정정신고' (Amendment to Securities Registration Statement for Equity Securities) filed by PeopleBio. It details changes to the public offering schedule, including demand forecasting, subscription dates, and payment dates. This is a formal regulatory filing required for equity offerings and does not fit into the other specific categories like Earnings Release or Annual Report. It is a primary regulatory document rather than an announcement of a report.
2020-08-31 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.